LLY
Eli Lilly and Company
LLY has the edge over WGS overall, supported by stronger fundamentals and lower modeled downside.
WGS
GeneDx Holdings Corp.
WGS's outlook is improving, though it still trails on the overall score.
LLY Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Healthy |
LLY's revenue, profitability, cash flow and balance sheet are all currently healthy.
WGS Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Weak | |
| Weak | |
| Strong |
WGS's balance sheet is currently strong, and its revenue is stable, but its profitability and cash flow are weak.
LLY PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 27x | $845 | -41% |
| Forward | 30x | $1,427 | — |
| Current | 46x | $1,427 | — |
| Fair | 48x | $1,466 | +2.7% |
| Expensive | 85x | $2,612 | +83% |
Historical ranges are pointers, not guarantees.
LLY's PE is in its fair range at 46x. If earnings grow as analysts expect, today's price would be 30x next year's earnings, in its cheap range.
WGS PE Valuation
WGS has no meaningful PE right now: it lost money over the past year. If it returns to profit as analysts expect, today's price would be 59x next year's earnings.
LLY Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for LLY, with profitability improving.
WGS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect WGS to return to profit, with revenue growing.
LLY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $46.82 | +52% |
| Q3 2026 | $30.81 | +51% |
| Q2 2026 | $29.80 | +95% |
| Q1 2026 | $28.15 | +129% |
| Q4 2025 | $22.95 | +96% |
| Q3 2025 | $20.44 | +121% |
| Q2 2025 | $15.30 | +88% |
| Q1 2025 | $12.29 | +81% |
| Q4 2024 | $11.71 | +102% |
LLY has the edge over WGS on earnings quality, reporting a profit while its opponent remains loss making.
WGS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.88 | — |
| Q3 2026 | -$3.76 | -3518% |
| Q2 2026 | -$3.62 | -5271% |
| Q1 2026 | -$2.66 | -$1.27 |
| Q4 2025 | -$0.73 | +$1.21 |
| Q3 2025 | $0.11 | +$3.01 |
| Q2 2025 | $0.07 | +$4.30 |
| Q1 2025 | -$1.39 | +$3.58 |
| Q4 2024 | -$1.94 | +$5.29 |
WGS has swung to a loss: it lost $3.76 per share over the past year, after a profit the year before.
LLY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.4B | +39% |
| Q2 2026 | $23B | +48% |
| Q1 2026 | $19.8B | +56% |
| Q4 2025 | $19.3B | +43% |
| Q3 2025 | $17.6B | +54% |
| Q2 2025 | $15.6B | +38% |
| Q1 2025 | $12.7B | +45% |
| Q4 2024 | $13.5B | +45% |
LLY has the edge over WGS on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 34% | -6.6 points |
| Q2 2026 | 40% | -3.3 points |
| Q1 2026 | 45% | +18 points |
| Q4 2025 | 43% | +5.6 points |
| Q3 2025 | 41% | +27 points |
| Q2 2025 | 44% | +12 points |
| Q1 2025 | 27% | -1.8 points |
| Q4 2024 | 37% | +10 points |
LLY has the edge over WGS on profitability, with a higher operating margin.
WGS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $123.1M | +5.4% |
| Q2 2026 | $114.4M | +11% |
| Q1 2026 | $102.3M | +17% |
| Q4 2025 | $121M | +27% |
| Q3 2025 | $116.7M | +52% |
| Q2 2025 | $102.7M | +46% |
| Q1 2025 | $87.1M | +40% |
| Q4 2024 | $95.6M | +67% |
WGS's revenue has grown year over year for 11 quarters in a row: $123M last quarter, up 5.4% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -8.5% | -5.7 points |
| Q2 2026 | -15% | -24 points |
| Q1 2026 | -56% | -51 points |
| Q4 2025 | -12% | -21 points |
| Q3 2025 | -2.8% | +7.3 points |
| Q2 2025 | 8.7% | +24 points |
| Q1 2025 | -5.2% | +17 points |
| Q4 2024 | 9.2% | +54 points |
WGS's operating margin was −8.5% last quarter, down 5.7 points from the same quarter a year ago.
LLY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $8.2B | +22% |
| Q2 2026 | $7.8B | +458% |
| Q1 2026 | $3B | +1826% |
| Q4 2025 | $677.9M | -31% |
| Q3 2025 | $6.7B | +186% |
| Q2 2025 | $1.4B | +476% |
| Q1 2025 | $156.1M | -13% |
| Q4 2024 | $977.8M | +$2.4B |
LLY has the edge over WGS on cash generation, producing positive trailing cash flow while its opponent burns cash.
WGS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$15.8M | -265% |
| Q2 2026 | -$39.1M | -586% |
| Q1 2026 | -$38.9M | -1059% |
| Q4 2025 | -$7.4M | -$1.2M |
| Q3 2025 | $9.6M | +$14.6M |
| Q2 2025 | $8.1M | +$13.9M |
| Q1 2025 | $4.1M | +$20.9M |
| Q4 2024 | -$6.2M | +$26M |
WGS has burned cash in almost every quarter: −$101M over the past year, against $15M the year before.
LLY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -300K shares |
| 1 year | -0.6% | -5.4M shares |
| 3 years | -0.7% | -6.4M shares |
| 5 years | -1.9% | -17.4M shares |
| Available history | -4.5% | -42.3M shares |
LLY has the edge over WGS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $377M |
| Q2 2026 | $1.6B |
| Q1 2026 | $2.4B |
| Q4 2025 | $1.5B |
| Q3 2025 | $708.1M |
| Q2 2025 | $692.2M |
| Q1 2025 | $1.2B |
| Q4 2024 | $2.1B |
LLY spent $5.8B buying back its own shares over the past year, up 26% from the year before.
WGS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.6% | +170K shares |
| 1 year | +3.8% | +1.1M shares |
| 3 years | +16% | +4.1M shares |
WGS has 30M diluted shares, up 3.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
LLY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.2x | Healthy |
| Q2 2026 | 1.3x | Healthy |
| Q1 2026 | 1.2x | Healthy |
| Q4 2025 | 1.3x | Healthy |
| Q3 2025 | 1.3x | Healthy |
| Q2 2025 | 2.0x | Healthy |
| Q1 2025 | 2.3x | Moderate |
| Q4 2024 | 2.1x | Moderate |
LLY's net debt is about 1.2 years of its operating earnings (EBITDA), about the same as a year ago.
WGS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2025 | -2.3x | Net Cash |
| Q2 2025 | -1.5x | Net Cash |
WGS has more cash than debt.
LLY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 68.3 | Neutral |
| Stochastic | 84.1 | Overbought |
LLY's weekly RSI is 68 (neutral) and its Stochastic is 84 (overbought).
WGS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 39.6 | Neutral |
| Stochastic | 14.6 | Oversold |
WGS's weekly RSI is 40 (neutral) and its Stochastic is 15 (oversold).
LLY PE vs Healthcare Sector
| Metric | LLY | Sector median | Relative |
|---|---|---|---|
| PE | 46x | 26x | 79% above |
| PE % | 48 | 29 | 19 pts above |
LLY is trading at 46x earnings, a 79% premium to the Healthcare sector's median of 26x.
WGS PE vs Healthcare Sector
| Metric | WGS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
WGS has no meaningful PE right now: it lost money over the past year.
LLY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,279.4 | 12% above |
| 20 week MA | $1,218.8 | 17% above |
| 50 week MA | $1,102.2 | 29% above |
| 100 week MA | $954.1 | 50% above |
| 200 week MA | $797.5 | 79% above |
LLY has the edge over WGS on trend strength, trading above more of its moving averages.
WGS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $66.5 | 22% below |
| 20 week MA | $72.7 | 29% below |
| 50 week MA | $79.8 | 35% below |
| 100 week MA | $89.1 | 42% below |
| 200 week MA | $54.0 | 4% below |
WGS is in a downtrend: it's below all five of its weekly moving averages, and 4% below its 200-week average.
LLY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $131.5 | $166.7 | +27% |
| 2021 | $166.7 | $273.1 | +64% |
| 2022 | $273.1 | $367.9 | +35% |
| 2023 | $367.9 | $582.9 | +58% |
| 2024 | $582.9 | $783.2 | +34% |
| 2025 | $783.2 | $1,077.8 | +38% |
| 2026 YTD | $1,077.8 | $1,427.3 | +32% |
LLY has the edge over WGS on returns for 2026, with the stronger performance.
WGS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $323.4 | $382.5 | +18% |
| 2021 | $382.5 | $154.1 | -60% |
| 2022 | $154.1 | $8.02 | -95% |
| 2023 | $8.02 | $2.75 | -66% |
| 2024 | $2.75 | $78.1 | +2738% |
| 2025 | $78.1 | $133.8 | +71% |
| 2026 YTD | $133.8 | $51.9 | -61% |
WGS's yearly returns have swung widely, from +2738% in 2024 to −95% in 2022. It's down 61% so far in 2026.